Eitan Kerem

Research interests

Publications

• Complicated pneumonia in children

  The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)31550-6

• Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis

  New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1709847

• Pathogenetics of alveolar capillary dysplasia with misalignment of pulmonary veins

  Human Genetics · 2016 · 10.1007/s00439-016-1655-9

• Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial

  The Lancet Respiratory Medicine · 2014 · 10.1016/s2213-2600(14)70100-6

• Factors associated with FEV1decline in cystic fibrosis: analysis of the ECFS Patient Registry

  European Respiratory Journal · 2013 · 10.1183/09031936.00166412

• Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications

  Thorax · 2013 · 10.1136/thoraxjnl-2013-203204

• Recommendations for the classification of diseases as CFTR-related disorders

  Journal of Cystic Fibrosis · 2011 · 10.1016/s1569-1993(11)60014-3

• Managing Cystic Fibrosis: Strategies That Increase Life Expectancy and Improve Quality of Life

  American Journal of Respiratory and Critical Care Medicine · 2011 · 10.1164/rccm.201009-1478ci

• Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis

  European Respiratory Journal · 2011 · 10.1183/09031936.00120910

• Evidence of Intestinal Inflammation in Patients With Cystic Fibrosis

  Journal of Pediatric Gastroenterology and Nutrition · 2010 · 10.1097/mpg.0b013e3181d1b013

• Multicenter Cross-Sectional Study of Nontuberculous Mycobacterial Infections among Cystic Fibrosis Patients, Israel

  Emerging infectious diseases · 2008 · 10.3201/eid1403.061405

• Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial

  The Lancet · 2008 · 10.1016/s0140-6736(08)61168-x

• Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice

  Journal of Cystic Fibrosis · 2008 · https://doi.org/10.1016/j.jcf.2008.03.009

• Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin

  Journal of Clinical Investigation · 2007 · 10.1172/jci28523

• Aspergillus Bronchitis in Cystic Fibrosis

  CHEST Journal · 2006 · 10.1378/chest.130.1.222

• Standards of care for patients with cystic fibrosis: a European consensus

  Journal of Cystic Fibrosis · 2005 · 10.1016/j.jcf.2004.12.002

• Gentamicin-Induced Correction of CFTR Function in Patients with Cystic Fibrosis and CFTR Stop Mutations

  New England Journal of Medicine · 2003 · https://doi.org/10.1056/nejmoa022170

• A Pilot Study of the Effect of Gentamicin on Nasal Potential Difference Measurements in Cystic Fibrosis Patients Carrying Stop Mutations

  American Journal of Respiratory and Critical Care Medicine · 2000 · 10.1164/ajrccm.161.3.9904116

• Pulmonary Epithelial Sodium-Channel Dysfunction and Excess Airway Liquid in Pseudohypoaldosteronism

  New England Journal of Medicine · 1999 · 10.1056/nejm199907153410304

• The molecular basis of partial penetrance of splicing mutations in cystic fibrosis.

  PubMed · 1997

• Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma

  The Journal of Pediatrics · 1993 · 10.1016/s0022-3476(05)81710-x

• Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease.

  PubMed · 1992

• Prediction of Mortality in Patients with Cystic Fibrosis

  New England Journal of Medicine · 1992 · https://doi.org/10.1056/nejm199204303261804

• The Relation between Genotype and Phenotype in Cystic Fibrosis — Analysis of the Most Common Mutation (ΔF 508 )

  New England Journal of Medicine · 1990 · https://doi.org/10.1056/nejm199011293232203

• Nebulized albuterol in acute bronchiolitis

  The Journal of Pediatrics · 1990 · 10.1016/s0022-3476(05)80706-1

Current projects

No projects listed.